- Multaq
- Dosage: 400 mg BID
- Formulation: T 400
- Comments (Metabolism): Contraindicated in New York Heart Association class IV heart failure, recent hospitalization for decompensated heart failure, or permanent atrial fibrillation; contraindicated in severe hepatic insufficiency; use with caution in patients with HFrEF with less severe symptoms (NYHA class I or II); no dosage adjustment for renal impairment
Notes:
* following a drug name indicates the drug is available as a generic formulation.
BC following a drug name indicates the drug is listed in the 2023 American Geriatrics Society Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.
K = renal elimination; L = hepatic elimination